Myxedema Coma Diagnostic Score
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Unlikely0–24
- Possible25–44
- At Risk45–59
- Diagnostic60–100
The Myxedema Coma Diagnostic Score calculates evaluating glycemic control, metabolic decompensation severity, and long-term endocrine risks. Key inputs include body temperature. Scores guide titrating insulin infusion protocols, managing fluid-electrolyte resuscitation, and long-term risk reduction. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Diagnostic scoring system for myxedema coma (MC), a rare but life-threatening decompensated state of extreme hypothyroidism. This validated scoring system facilitates early recognition and treatment by evaluating thermoregulatory, central nervous, cardiovascular, gastrointestinal, and metabolic dysfunction along with precipitating events.
Clinical Indication
The Myxedema Coma Diagnostic Score is indicated for bedside clinical practice to support Diagnostic scoring system for myxedema coma (MC), a rare but life-threatening decompensated state of extreme hypothyroidism. This validated scoring system facilitates early recognition and treatment by evaluating thermoregulatory, central nervous, cardiovascular, gastrointestinal, and metabolic dysfunction along with precipitating events.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with diabetes mellitus, diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state, thyroid storm, or adrenal crisis. Clinical application is indicated across Endocrinology clinics, inpatient metabolic services, and acute diabetes care units.
Limitations & Contraindications
Severe hyperglycemia lowers measured serum sodium; corrected sodium equations must guide intravenous fluid selection.
Clinical Pearls & Action Plan
Serial monitoring of serum electrolytes, potassium kinetics, venous pH, and anion gap is mandatory during acute metabolic crisis management. Guideline pearl: The scoring system has 100% sensitivity and 85.71% specificity at a cutoff score of 60.
Myxedema Coma Score = Body Temperature Points + Central Nervous System Points + Cardiovascular Points + Gastrointestinal Points + Metabolic Points + Precipitating Event Points
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| body_temperature | string | Yes | Core body temperature reflecting thermoregulatory dysfunction in severe hypothyroidism |
| central_nervous_system | string | Yes | Central nervous system manifestations of severe hypothyroidism affecting consciousness and neurological function |
| cardiovascular_dysfunction | string | Yes | Cardiovascular manifestations including heart rate, blood pressure, and cardiac function abnormalities |
| gastrointestinal_dysfunction | string | Yes | Gastrointestinal manifestations including constipation, ileus, and motility disorders |
| metabolic_dysfunction | string | Yes | Metabolic abnormalities including hyponatremia, hypoglycemia, and other electrolyte disturbances |
| precipitating_event | string | Yes | Presence of precipitating events that may trigger myxedema coma in patients with severe hypothyroidism |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–24 | Unlikely | Myxedema coma unlikely |
| 25–44 | Possible | Myxedema coma possible but unlikely |
| 45–59 | At Risk | Patient at risk for myxedema coma |
| 60–100 | Diagnostic | Highly suggestive of myxedema coma |
Evidence-Based References (EBM)
- Popoveniuc G, Chandra T, Sud A, Sharma M, Blackman MR, Burman KD, et al. A diagnostic scoring system for myxedema coma. Endocr Pract. 2014;20(8):808-17. doi: 10.4158/EP13460.OR.DOI: 10.4158/EP13460.OR
- Mathew V, Misgar RA, Ghosh S, Mukhopadhyay P, Roychowdhury P, Pandit K, et al. Myxedema coma: a new look into an old crisis. J Thyroid Res. 2011;2011:493462. doi: 10.4061/2011/493462.DOI: 10.4061/2011/493462
- Wall CR. Myxedema coma: diagnosis and treatment. Am Fam Physician. 2000;62(11):2485-90.